AquaBounty Technologies, Inc. (AQB) est une société cotée en bourse dans le Consommation Défensive secteur, opérant dans le Agricultural Farm Products secteur d'activité. Le siège social de l'entreprise est situé à Maynard, MA, United States. Le PDG actuel est David A. Frank.
AQB a date d'introduction en bourse 2017-01-11, 4 employés à temps plein, cotée sur le NASDAQ Capital Marke, une capitalisation boursière de $3.96M.
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
